compound vs name brand tirzepatide COMPOUNDED Compounded Tirzepatide With B6 (Pyridoxine)

Description

Current annual therapy cost: ~1.51.7 lakh per patient At 5060% lower pricing: ~70,00085,000 per year Savings of nearly 80,0001,00,000 per patient annually Now consider scale: 100,000 patients 75,000 750 crore annual market 500,000 patients (just ~0.5% of high-risk obese population) 3,750 crore opportunity And thats only drug revenue

Discover how to choose the best treatment tailored to your needs and goals.

Crush Cravings and Feel In Control All Day Long

Each AMCs de-identified data environment is specifically designed and operated to enable access to and analysis of de-identified data without the need for Institutional Review Board (IRB) oversight, approval, or an exemption confirmation

A systemic review of semaglutide studies found lean mass reductions ranging from negligible to 40% of total weight lost, with larger studies showing more significant losses